2 studies found for:    9820297 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS
Condition: Multiple Sclerosis
Interventions: Drug: Rebif (IFN β-1a subcutaneous three times per week);   Drug: Tecifdera (dimethyl fumarate)
2 Unknown  Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients
Condition: Multiple Sclerosis
Interventions: Drug: estroprogestins;   Drug: interferon-beta 1a

Indicates status has not been verified in more than two years